Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yazan Alnajdawi"'
Autor:
Hubertus Hautzel, Yazan Alnajdawi, Wolfgang P. Fendler, Christoph Rischpler, Kaid Darwiche, Wilfried E. Eberhardt, Lale Umutlu, Dirk Theegarten, Martin Stuschke, Martin Schuler, Clemens Aigner, Ken Herrmann, Till Plönes
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Background Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare entity occurring in less than 4% of all lung cancers. Due to its low differentiation and high glucose transporter 1 (GLUT1) expression, LCNEC demonstrates an increa
Externí odkaz:
https://doaj.org/article/084f39ecd15a4dfbbb4deb425b97b489
Autor:
Lale Umutlu, Clemens Aigner, Dirk Stefani, Keita Tokuishi, Daniel Valdivia, Stéphane Collaud, Hubertus Hautzel, Yazan Alnajdawi, Till Plönes, M Zaatar, Theresa Stork, Balazs Hegedus
Publikováno v:
Lung Cancer. 154:23-28
Objectives Preoperative planning of lung resection extent is decisive for preoperative functional work-up and selection for multimodal treatment. It is mainly based on preoperative chest CT. We aimed at evaluating chest CT adequacy to predict the ext
Autor:
Lale Umutlu, Ken Herrmann, Dirk Theegarten, Till Plönes, Hubertus Hautzel, Clemens Aigner, Martin Stuschke, Yazan Alnajdawi, Christoph Rischpler, Wilfried Eberhardt, Kaid Darwiche, Martin Schuler, Wolfgang P. Fendler
Publikováno v:
EJNMMI Research
EJNMMI Research, Vol 11, Iss 1, Pp 1-9 (2021)
EJNMMI Research, Vol 11, Iss 1, Pp 1-9 (2021)
Background Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare entity occurring in less than 4% of all lung cancers. Due to its low differentiation and high glucose transporter 1 (GLUT1) expression, LCNEC demonstrates an increased gluco
Autor:
Hubertus Hautzel, Yazan Alnajdawi, Wolfgang P Fendler, Christoph Rischpler, Kaid Darwiche, Wilfried E Eberhardt, Lale Umutlu, Dirk Theegarten, Martin Stuschke, Martin Schuler, Clemens Aigner, Ken Herrmann, Till Plönes
Background:Large cell neuroendocrine carcinomas of the lung (LCNEC) is a rare entity occurring in less than 4% of all lung cancers. Due to its low differentiation and high glucose transporter 1 (GLUT1) expression LCNEC demonstrates an increased gluco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b40ec55bc0d34ad5d358ff63ae28d88f
https://doi.org/10.21203/rs.3.rs-513428/v1
https://doi.org/10.21203/rs.3.rs-513428/v1
Autor:
Till Plönes, Clemens Aigner, Christian Roesel, Stefan Welter, Gerhard Weinreich, Monika Serke, Karl-Otto Kambartel, Yazan Alnajdawi, Mohammed Ibrahim, Thomas Krbek
Background: Large cell neuroendocrine carcinomas (LCNEC) are rare pulmonary malignancies. Reported survival rates are heterogeneous and the optimal therapeutic strategy is still debated. The prognosis of LCNEC is generally inferior compared to other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67545569ac7e1ca7efb7ffcd70e039d0
https://europepmc.org/articles/PMC7139022/
https://europepmc.org/articles/PMC7139022/